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Abstract
Background: The c-fos gene was originally identified as the cellular homolog of the oncogene v-
fos  carried by the Finkel-Biskis-Jenkins and Finkel-Biskis-Reilly murine osteogenic sarcoma
retroviruses. Sustained expression of fos is sufficient to induce cellular transformation in vitro and
tumorigenesis in vivo. Fos functions as a component of the AP-1 transcription factor complex to
regulate gene transcription and several differentially expressed genes have been identified in cells
transformed by fos. We have extended these studies by constructing a cellular system for
conditional transformation by v-fos. Using Affymetrix-based DNA microarray technology, we
analyzed transcriptional changes over the course of transformation and reversion in an inducible v-
fos system.
Results: Microarray analyses of temporal gene expression during the process of v-fos mediated
cellular transformation and morphological reversion revealed a remarkably dynamic transcriptome.
Of the more than 8000 genes analyzed in this study, 3766 genes were categorized into 18 gene-
expression patterns by using self-organizing map analysis. By combining the analysis of gene
expression profiles in stably transformed cells with the analysis of sequential expression patterns
during conditional transformation, we identified a relatively small cohort of genes implicated in v-
fos mediated cellular transformation.
Conclusion: This approach defines a general conditional cell transformation system that can be
used to study the endogenous transcription regulatory mechanisms involved in transformation and
tumorigenesis. In addition, this study is the first reported analysis of dynamic changes in gene
expression throughout experimentally controlled morphological transformation mediated by v-fos.
Background
The c-fos  proto-oncogene encodes an immediate-early
transcription factor that is rapidly and transiently induced
by a variety of extracellular stimuli associated with cellular
responses such as proliferation, differentiation, apoptosis
and neuronal signalling [1]. The c-Fos protein functions
by forming leucine zipper dimers with members of the
Jun and ATF/CREB families that comprise the transcrip-
tion factor complexes collectively referred to as AP-1 [2].
The tightly regulated expression and activity of AP-1 fam-
ily members defines a prototypical mechanism whereby
short-term extracellular signals are coupled to appropriate
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long-term changes in cellular phenotype by selective reg-
ulation of gene expression.
The identification of v-fos as the oncogene carried by the
Finkel-Biskis-Jenkins and Finkel-Biskis-Reilly murine
osteosarcoma retroviruses contributed to the realization
that tumorigenic retroviruses harbor viral versions of cel-
lular genes and that these genes can elude the regulatory
constraints imposed upon the endogenous gene [3-5].
The viral fos oncogenes contain point mutations and dele-
tions that enhance their transforming potential [6]. How-
ever, sustained expression of c-fos is sufficient to induce
cellular transformation in vitro and tumorigenesis in vivo
[7]. Therefore, fos-induced transformation and tumori-
genesis is the consequence of inappropriate fos activity
within susceptible cells rather than a gain-of-function
mechanism specific to the viral fos oncogene.
Many signal transduction pathways implicated in tumori-
genesis functionally converge on activation of c-fos and
AP-1, suggesting that inappropriate activation of c-fos con-
tributes to various aspects of tumorigenesis. This contri-
bution involves direct transcriptional regulation of AP-1
target genes and secondary mechanisms of transcriptional
regulation. For example, increased expression and activity
of Dnmt1, a DNA methyltransferase that methylates CpG
dinucleotides [8], is necessary for morphological transfor-
mation by c-fos [9]. CpG methylation within promoter
regions functions as an epigenetic mark that establishes or
maintains transcriptional repression by recruiting chro-
matin modification machinery [10]. A previous study
identified specific genes that are irreversibly silenced in
association with DNA hypermethylation in fos-trans-
formed cells [11]. Therefore, during fos-mediated transfor-
mation, there is conditional deregulation of target gene
expression dependent upon continual oncogene activity,
in addition to long-term epigenetic reprogramming of
gene expression that can persist even when the direct
effects of oncogene activity are suppressed.
Studies of stably transformed cell lines have found gene
expression changes associated with fos transformation and
have yielded functional data that implicate differentially
expressed genes in aspects of oncogenic transformation
[12-14]. In the study described here, we took advantage of
a conditional cellular system (LacIv-fos) that allows con-
trol of v-fos expression and morphologic transformation.
This approach refines the analysis of gene expression asso-
ciated with fos  transformation by distinguishing gene
expression changes coincident with morphological trans-
formation from those that are potentially associated with
clonal variation or phenotypic changes that occur down-
stream of the transformation process. Comparisons of
temporal gene expression patterns during conditional cel-
lular transformation with transcriptome profiles of cells
stably transformed by c-fos and v-fos revealed a cohort of
genes likely to be critical for induction and maintenance
of cellular transformation.
Results
Inducible lacIv-fos system
In the LacIv-fos  cell system, the control of FBJ/R v-fos
expression is dependent on the presence of isopropyl-b-
D-thiogalactopryanoside (IPTG) in the cell culture
medium [11]. In the presence of 5 mM IPTG, LacIv-fos
cells did not express v-Fos protein detectable by Western
blot analysis (Figure 1a). When IPTG was washed away,
LacIv-fos cells expressed v-Fos protein with peak expres-
sion detected at 72 hours following removal of IPTG and
progressive loss of v-Fos protein levels upon re-addition
of IPTG. In addition, cells were morphologically trans-
formed within a 72-hour period. Transformation was
indicated by an overall change in cell shape that led to a
more rounded and light refractory morphology as well as
dramatic cytoskeletal alterations (Figure 1b). When IPTG
was added back to these transformed cells, v-Fos expres-
sion was again repressed and the cells returned to their
original morphology within a 72-hour reversion period.
Self-organizing map analysis
The ability to control both v-Fos expression and morpho-
logical transformation in vitro provides an opportunity to
investigate global gene expression changes relative to the
temporal v-Fos cellular transformation and reversion
process. RNA was extracted from LacIv-fos  cells treated
with 5 mM IPTG at time zero (t = 0); from cells at 24, 48
and 72 hours following the removal of IPTG (transform-
ing); and from cells at 24, 48 and 72 hours after the re-
addition of 5 mM IPTG (reverting). Previous studies have
demonstrated that the addition and removal of IPTG does
not itself induce persistent changes in gene expression in
the parental 208F rat fibroblast cell line [9,11]. RNA sam-
ples were processed and analyzed by hybridization to
Affymetrix rat U34A GeneChip microarrays.
Self-organizing map (SOM) analysis is a powerful tool
that can be used to categorize gene expression data into
groups that share common temporal expression profiles
[15-17]. To identify patterns of gene expression, we cre-
ated an SOM by using the LacIv-fos  microarray data
obtained at the seven time points throughout v-Fos trans-
formation and reversion (Figure 2a). The data were
mapped into 18 groups that provided the greatest pattern
distinction among groups as well as the best pattern con-
sistency within groups. Several assumptions were made
on the basis of simple visualization of the map. For exam-
ple, the expression of genes grouped into pattern 1 peaked
24 hours following removal of IPTG, as well as at 24 hours
following re-addition of IPTG. This group likely repre-
sents genes whose expression was induced within 24Molecular Cancer 2005, 4:19 http://www.molecular-cancer.com/content/4/1/19
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Expression of v-Fos and cell morphology rearrangement in LacIv-fos system during conditional transformation and reversion Figure 1
Expression of v-Fos and cell morphology rearrangement in LacIv-fos system during conditional transformation 
and reversion. (A) Expression of v-Fos protein expression during conditional morphological transformation of LacIv-fos cells. 
At time zero (t = 0), Fos protein was not detectable in cells. 24 hours after removal of IPTG, Fos protein expression was 
induced and the immunoreactivity increased over the 72 hour transformation period. After re-addition of IPTG, Fos protein 
levels rapidly decreased with no detectable signal observed after 72 hours of reversion. (B) Induction of v-Fos expression 
resulted in dramatic cytoskeletal changes in LacIv-fos cells. Cells were stained with anti-vinculin antibody (green) to detect focal 
adhesion contact sites and phalloidin (red) was used to track alterations in the actin cytoskeleton. In the presence of IPTG (t = 
0), cells have well established focal adhesion sites and coordinated F-actin staining. Seventy-two hours after removal of IPTG (t 
= 72), cells lacked defined focal adhesion contacts and displayed disorganized F-actin stainingMolecular Cancer 2005, 4:19 http://www.molecular-cancer.com/content/4/1/19
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Self-organizing map (SOM) analysis of microarray expression data in the LacIv-fos system during morphological transformation  and reversion Figure 2
Self-organizing map (SOM) analysis of microarray expression data in the LacIv-fos system during morphologi-
cal transformation and reversion. (A) Results of SOM analysis of genes depicting co-regulated clusters of genes across the 
seven time points throughout v-Fos mediated morphological transformation and reversion. Genes whose expression did not 
change significantly across time points were eliminated by using a variance filter (see Methods). The 3766 probe sets (out of a 
possible 8799) that passed the variation filter were grouped into 18 clustered patterns. Blue bars at the top of each graph rep-
resent the relative number of probe sets included within the SOM bin. (B) A gene-expression heat map of genes within group 
8. This bin represents genes dramatically upregulated specifically during the 72 hour v-Fos transformation period (-IPTG). (C) 
Gene-expression heat map of genes within group 11. This bin represents genes displaying sustained downregulation during the 
72 hr v-Fos transformation period (+ITPG). Red signal represents upregulated genes and green represents downregulated 
genes. (D-E) Normalized expression values of all genes within group 8 (D) or group 11 (E) are plotted to demonstrate the reli-
ability of the representative SOM patterns shown in panel A.
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hours following culture media change rather than genes
whose expression coincided with v-Fos-mediated trans-
formation. Indeed, genes represented by pattern 1
included serum-responsive genes such as c-Jun and cyclin
D1. However, other patterns included genes that were reg-
ulated in a manner more consistent with conditional v-
Fos transformation and reversion. For example, pattern 8
included genes that were dramatically upregulated during
the 3-day transformation process, yet return to baseline
levels during the three-day reversion process (Figure 2b).
This group included two probe sets specific for FBR v-fos
included on the Affymetrix U34A GeneChip. These probe
sets give a reliable measurement of FBJ/R v-fos expression
and they did not cross-hybridize with endogenous c-fos
transcripts [11]. Conversely, group 11 represents genes
that were conditionally downregulated specifically during
conditional v-Fos transformation (Figure 2c). Plots of the
normalized signal values for each probe set included in
these groups further confirmed the reliability of the classi-
fications of gene expression profiles within the SOM (Fig-
ure 2d-e).
Patterns within the SOM that are consistent with v-Fos
transformation and reversion were selected on the basis of
the representative expression pattern of each SOM group.
For candidate genes whose expression was upregulated,
the standard deviation of the mean signal values at a min-
imum of two of the three time points in the absence of
IPTG (transforming) had to be greater than that of the
mean signal values at time zero (i.e., the time prior to
removal of IPTG from the culture medium). Also, the
standard deviation of the mean signal values at a mini-
mum of two of the three final time points in the presence
of IPTG (reverting) had to be below that of the mean sig-
nal value of the final time point during transformation
(i.e., 72 hours after removal of IPTG from the culture
medium). For candidate genes whose expression was
downregulated, the standard deviation of the mean signal
values at a minimum of two of the three transforming
time points had to be lower than that of the mean signal
values at time zero, and the standard deviation of the
mean signal values at a minimum of two of the three time
points during reversion had to be higher than that of the
final time point during transformation. On the basis of
these criteria, patterns 7, 8, 14 and 15 (transforming) and
patterns 5, 11, 12, 17 and 18 (reverting) were selected for
further analysis. Each of these groups consisted of a large
number of genes (Figure 2a). These groups likely included
not only genes functionally involved in cellular transfor-
mation, but also genes that share similar expression pro-
files during conditional transformation and reversion yet
have no role in the process or maintenance of cellular
transformation itself. Interestingly, both patterns 5 and 7
included genes with higher signal-ratio values at the end
of morphological reversion (t = 72 hours, reverting) than
prior to v-fos induction (t = 0). This difference in tran-
script levels at the beginning of the time course relative to
the final time point may be related to a requirement for a
higher level of expression of particular genes during the
reversion of morphological transformation than during
maintenance of the non-transformed state. Alternatively,
this may reflect a type of over-compensation in that
expression levels within particular expression pattern
groups and transcript levels may not completely return to
steady-state within the three-day reversion period.
Stable versus inducible v-fos expression
To identify only the most promising candidate genes, we
compared these datasets with gene expression profiles of
the parental 208F cells and 208F cells transformed by sta-
ble expression of either c-Fos (CMVc-fos cells) or v-Fos
(FBJ/R cells). Cells transformed by stable expression of c-
Fos or v-Fos exhibit a large number of differentially
expressed genes. For example, when differential expres-
sion was defined as a 2-fold increase or decrease based on
a comparison with expression in 208F cells and when
probe sets for expressed sequence tags (ESTs) were
excluded, 70 probe sets were scored as upregulated and
104 were scored as downregulated in both CMVc-fos and
FBJ/R cells [11]. However, eliminating genes whose
expression changes are consistent in both stably and con-
ditionally transformed cell model systems can reduce the
level of nonspecific transcriptional variation. Of the 174
differentially expressed probe sets identified in
comparisons of both CMVc-fos and FBJ/R cells to 208F
cells, 63 (36%) were also categorized into LacIv-fos SOM
patterns consistent with increased or decreased expression
during conditional v-Fos transformation. Therefore, the
majority of gene expression changes associated with sta-
bly Fos-transformed cell lines were not recapitulated dur-
ing conditional v-Fos transformation and reversion. These
findings emphasize the value of combining analyses of
stable and conditional cellular transformation systems.
To address the reproducibility of gene expression changes
during conditional v-Fos transformation, we performed
microarray analysis using RNA samples isolated from
LacIv-fos  cells at time points during a second LacIv-fos
transformation and reversion time course experiment. To
maintain stringent biological replication of the experi-
ment, these seven time points were treated as an inde-
pendent experiment rather than as expression values that
could be averaged between experiments. Expression pat-
terns of genes differentially expressed in both CMVc-fos
and FBJ/R cells relative to 208F cells, as well as condition-
ally regulated within the LacIv-fos SOM obtained from the
first experiment, were compared to expression patterns
obtained from the independent LacIv-fos transformation
and reversion time course experiment. Of the 63 probe
sets representing differentially expression in stably Fos-Molecular Cancer 2005, 4:19 http://www.molecular-cancer.com/content/4/1/19
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transformed cells and conditional regulation in the LacIv-
fos SOM, 40 (64%) demonstrated a reproducible tempo-
ral profile of gene expression in the independent LacIv-fos
transformation and reversion time course experiment
(Additional file 1 and Figure 3). In addition, a previous
study indicated by Northern blot analysis that representa-
tive genes (i.e. TGF-β  3 and CAIII) had nearly identical
patterns of gene expression when compared to microarray
analysis [11]. Therefore, the combination of gene expres-
sion analysis of stably transformed cells with the analysis
of gene expression in an experimentally controlled condi-
tional transformation system is a useful approach to
reduce complicating transcriptional variation inherent in
any single cell model system.
c-fos versus v-fos gene regulation
Unlike c-fos, v-fos  contains several deletions and point
mutations that affect its oncogenic potential [18].
Although sustained expression of c-fos is capable of induc-
ing cellular transformation and tumorigenesis, v-fos is a
much more potent oncogene [7]. The increased tumori-
genic potential of v-Fos suggests that it directly or indi-
rectly influences the expression of genes not affected by c-
Fos. Consistent with this hypothesis, gene expression
Expression of representative genes conditionally regulated in LacIv-fos cells and differentially expressed in both CMVc-fos cells  and FBJ/R cells Figure 3
Expression of representative genes conditionally regulated in LacIv-fos cells and differentially expressed in 
both CMVc-fos cells and FBJ/R cells. Expression patterns of selected genes upregulated (A) or downregulated (B) specifi-
cally during conditional transformation, as well as in cells stably transformed by either c-Fos or v-Fos. Gene names are indi-
cated above each pair of graphs. Line graphs indicate raw signal values obtained from the two independent LacIv-fos time 
course experiments. Time points at 24, 48 and 72 hours in the absence of IPTG (transforming) and at 24, 48 and 72 hours after 
the re-addition of IPTG (reverting) are indicated by arrows below each line graph. Bar graphs indicate raw signal values 
obtained in microarray analyses of the parental 208F fibroblast cell line (white), the stably transformed c-fos cell line (CMVc-fos; 
grey) and the stably transformed v-fos cell line (FBJ/R; black).
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profile analyses to identify genes differentially expressed
by a 2-fold margin in FBJ/R cells, but not in CMVc-fos
cells, revealed a dramatic increase in the number of tran-
scriptionally upregulated genes in FBJ/R relative to CMVc-
fos  cells: 337 probe sets were scored as specifically
upregulated in FBJ/R cells, whereas only 70 probe sets
common to CMVc-fos and FBJ/R cells were considered as
increased. In contrast, 61 probe sets were scored as down-
regulated specifically in FBJ/R cells but 104 probe sets in
both CMVc-fos and FBJ/R cells were considered as down-
regulated [11]. These FBJ/R cell-specific changes in gene
expression were compared with the LacIv-fos SOM and the
results of the independent LacIv-fos transformation and
reversion time course as described previously. These com-
parisons revealed an additional 38 upregulated and 29
downregulated probe sets that are differentially regulated
in v-fos-transformed cells, but not in c-fos  transformed
cells (Tables 1 and 2, Figure 4).
LacIv-fos web-accessible database
The identification of conditionally regulated genes within
this system provides potentially unique opportunities to
investigate precise transcriptional regulatory mechanisms
of endogenous genes within an experimentally amenable
cellular context. Therefore, we assembled these datasets
into a web-accessible database equipped with various
Table 1: Genes whose expression was upregulated (i.e., increased by a factor≥  2) in FBJ/R cells (but not in CMVc-fos cells) and was 
conditionally regulated in LacIv-fos cells.
Upregulated v-Fos specific candidate genes
GenBank Accession No. Gene Pattern
AF100470 ribosome attached membrane protein 4 (RAMP4) 7
AF033027 prenylated SNARE protein Ykt6p (Ykt6) 7
AF036537 homocysteine respondent protein HCYP2 7
AF054618 cortactin isoform C 7
D00092 mRNA for 70 kd mitochondrial autoantigen 7
D30740 14-3-3 protein mRNA for mitochondrial import stimulation factor (MSF) S1 subunit 7
M21476 iodothyronine 5-monodeiodinase (5-MD) 7
M96630 sec61 homologue 7
U49930 ICE-like cysteine protease, Lice (aka Caspase 3) 7
U95161 nuclear protein E3-3 orf2 7
X13722 LDL-receptor 7
X70871 cyclin G 7
X92097 transmembrane protein rnp21.4 7
Y09332 cytosolic peroxisome proliferator-induced acyl-CoA thioesterase 7
AB015432 LAT1 (L-type amino acid transporter 1 8
AF069782 unknown mRNA (aka NAP65) 8
D16479 mitochondrial long-chain 3-ketoacyl-CoA thiolase beta-subunit of mitochondrial trifunctional protein 8
D26393 HK2 gene for type II hexokinase* 8
L12025 tumor-associated glycoprotein E4 (Tage4) 8
L12382 ADP-ribosylation factor 3 8
L19698 GTP-binding protein (ral A) 8
L38644 karyopherin beta 8
M62992 glycoprotein p62 8
U21718 clone C426 intestinal epithelium proliferating cell-associated mRNA 8
U38253 initiation factor eIF-2B gamma subunit (eIF-2B gamma) 8
X82445 C15 mRNA 8
Y00396 c-myc oncogene 8
M58587 interleukin 6 receptor ligand binding chain 14
M65253 transformation-associated protein, 34A (aka MMP10) 14
U17901 phospholipase A-2-activating protein (plap) 14
U35774 cytosolic branch chain aminotransferase 1, cytosolic 14
U92081 epithelial cell transmembrane protein antigen precursor (RTI40) 14
D12498 FGF receptor-1* 15
M74223 VGF mRNA 15
S54008 fibroblast growth factor receptor 1 beta-isoform* 15
S56464 hexokinase II (HK2)* 15
S81025 UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase homolog 15
J05166 band 3 Cl-/HCO3- exchanger, B3RP2 (aka Slc4a2) 15Molecular Cancer 2005, 4:19 http://www.molecular-cancer.com/content/4/1/19
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query functions so that users can mine the data to address
questions relevant to their own specific interests (see
methods). The initial interface of the database is the LacIv-
fos SOM (Figure 2a). Users can select SOM patterns of
interest to obtain a list of all probe sets mapped within
that common pattern of gene expression. Each probe set is
linked to the raw Affymetrix data for both independent
LacIv-fos  time course experiments. This arrangement
provides an opportunity for convenient confirmation of
consistent regulation between the independent time
course experiments. In addition, users can query the data-
base for information about specific genes by using Gen-
bank accession numbers or by using genes name as
keywords. Keyword queries may include the qualifier
functions "and" or "or". These queries will provide a list
of all probe sets matching the supplied criteria, and each
entry is again linked to the raw Affymetrix data obtained
from both independent LacIv-fos  time course
experiments.
Discussion
The process of cellular transformation involves complex
alterations of gene expression regulation. This level of
complexity raises the challenge of identifying the gene
expression changes that are most relevant to mechanisms
of tumorigenesis. The challenge is especially evident in
studies of primary tumor specimens in which the ana-
lyzed material represents the end state of a progressive
series of events rather than a snapshot of the process itself.
Cell-based model systems of transformation and tumori-
genesis offer an opportunity to experimentally simulate
steps along the pathway of transformation; however,
these systems are subject to their own set of caveats
including gene expression changes resulting from
variation inherent to cell culture conditions and clonal
variation. In the study described here, we attempted to
provide a more focused view of relevant gene expression
changes associated with oncogenic cellular transforma-
tion by analyzing a conditional cell-based model system
Table 2: Genes whose expression was downregulated (i.e., decreased by a factor ≥  2) in FBJ/R cells (but not in CMVc-fos cells) and was 
conditionally regulated in LacIv-fos cells.
Downregulated v-Fos-specific candidate genes
GenBank Accession No. Gene Pattern
M64780 agrin 5
M38135 cathepsin H (RCHII) 11
U52663 peptidylglycine alpha-amidating monooxygenase (PAM) 11
U75917 clathrin-associated protein 17 (AP17) 11
U75929 SPARC (aka osteonectin)* 11
X05341 3-oxoacyl-CoA thiolase 11
D10026 glutathione S-transferase Yrs-Yrs 12
J02791 acyl coenzyme A dehydrogenase medium chain 12
J03752 glutathione S-transferase 12
M93257 cathechol-O-methyltransferase 12
X05472 Rat 2.4 kb repeat DNA right terminal region 12
X74593 sorbitol dehydrogenase 12
Y09333 mitochondrial very-long-chain acyl-CoA thioesterase 12
AF034218 hyaluronidase (Hyal2) 17
AF065387 vitamin K-dependent gamma-glutamyl carboxylase 17
J02810 prostate glutathione S-transferase 17
J05031 isovaleryl-CoA dehydrogenase (IVD) 17
L01702 protein-tryosine-phosphatase (LRP) 17
U10357 pyruvate dehydrogenase kinase 2 subunit p45 (PDK2) 17
U25651 phosphofructokinase muscle isozyme 17
U75928 SPARC (aka osteonectin)* 17
Y13714 osteonectin (aka SPARC)* 17
D00512 mitochondrial acetoacetyl-CoA thiolase precursor 18
D13921 mitochondrial acetoacetyl-CoA thiolase 18
D16309 cyclin D3 18
M60921 NGF-inducible anti-proliferative putative secreted protein (PC3) 18
S7259 tissue inhibitor of metalloproteinase type 2 18
X95986 CBR gene 18Molecular Cancer 2005, 4:19 http://www.molecular-cancer.com/content/4/1/19
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in which morphological transformation and reversion is
experimentally manipulated.
Sustained expression of fos  results in the differential
expression of a large number of genes [7,9,11]. By analyz-
ing gene expression at time points throughout the condi-
tional cellular transformation and reversion of LacIv-fos
cells and by arranging these patterns into SOMs, we have
clustered differentially expressed genes into cohorts with
common temporal patterns of expression. This type of
clustering allows identification of groups of genes with
expression patterns that are consistent with a potential
functional role in the process of morphological
transformation. For example, the exogenous v-fos  tran-
script itself is clustered within the conditionally upregu-
lated group 8. This group also includes the previously
reported Fos-regulated target genes such as ezrin [19] and
Fra-1 [20,21] genes shown to be strongly upregulated in
response to fos-induced transformation [19,21]. Interest-
ingly, independent genes with functionally related roles in
cellular transformation fall into different expression pat-
tern bins. For example, ezrin and CD44 form a complex
that plays an active role in aspects of tumor progression
and metastasis such as tumor-endothelium interactions,
Expression of representative genes conditionally regulated in LacIv-fos cells and stably regulated in FBJ/R cells, but not CMVc- fos cells Figure 4
Expression of representative genes conditionally regulated in LacIv-fos cells and stably regulated in FBJ/R cells, 
but not CMVc-fos cells. Expression patterns of selected genes upregulated (A) or downregulated (B) specifically during con-
ditional transformation, as well as in cells stably transformed by v-Fos. Gene names are indicated above each pair of graphs. 
Line graphs indicate raw signal values obtained from the two independent LacIv-fos time course experiments. Time points at 
24, 48 and 72 hours in the absence of IPTG (transforming) and at 24, 48 and 72 hours after the re-addition of IPTG (reverting) 
are indicated by arrows below each line graph. Bar graphs indicate raw signal values obtained in microarray analyses of the 
parental 208F fibroblast cell line (white), the stably transformed c-Fos cell line (CMVc-fos; grey) and the stably transformed v-
Fos cell line (FBJ/R; black).
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cell migration and cell adhesion [22] but the expression
patterns of these two genes differ somewhat. The expres-
sion of CD44 is more transiently induced (group 7); this
characteristic is consistent with features of a gene whose
expression is induced in response to serum stimulation. In
contrast, ezrin  expression is maintained at its maximal
level throughout the 3-day morphological transformation
period and rapidly returns to its initial expression levels
upon repression of exogenous v-fos expression (group 8).
These results demonstrate that coordinated yet distinct
programs of gene expression regulation can be initiated to
affect the expression of genes that function in common
mechanisms of cellular transformation.
Our analysis has revealed additional conditionally regu-
lated genes that have not been previously associated
directly with Fos or AP-1. For example, PRL-1 is a protein
tyrosine phosphatase originally identified as an immedi-
ate-early gene in liver regeneration [23]. PRL-1 expression
is elevated in cells stably transformed by either c-fos or v-
fos, and it is conditionally upregulated during LacIv-fos
transformation (group 8). PRL-1 promotes cell migration
and invasion in vitro and its expression is elevated in a
number of cancer cell lines. PRL-1 is also involved in reg-
ulation of progression through mitosis, possibly by mod-
ulating spindle dynamics [24,25].
Sustained expression of c-Fos is capable of initiating trans-
formation [7]; however, in our study a comparison of c-
Fos transformed cells (CMVc-fos) with v-Fos transformed
cells revealed additional differential gene regulation
events in cells transformed by v-Fos relative to cells trans-
formed by c-Fos. For example, expression signal values of
both c-myc and the Ras GTPase, RalA, were slightly greater
in CMVc-fos cells relative to 208F cells. However, expres-
sion of these genes was dramatically upregulated (>2fold)
in FBJ/R cells. Likewise, PCPE and SPARC expression was
slightly downregulated in CMVc-fos cells, but were dra-
matically repressed in FBJ/R cells. In contrast, two genes
involved in enzymatic regulation of the extracellular
matrix were differentially expressed only in FBJ/R cells.
Expression of the matrix metalloproteinase MMP10 and
the metalloproteinase inhibitor TIMP2  was specifically
upregulated and downregulated in v-fos-transformed cells,
respectively. Interestingly, MMP10  was previously
identified as a gene whose expression was upregulated
gene in cells stably transformed by FBR-v-fos [14]. The
mechanisms responsible for differential expression of
these genes specifically in v-fos-transformed cells are cur-
rently unknown. Some of these genes may be direct targets
of v-Fos, but not of c-Fos, or targets of secondary transcrip-
tion regulatory factors whose expression is deregulated
specifically in v-fos-transformed cells. Alternatively, the
expression of some genes may be affected by both c-Fos
and v-Fos, but to a higher degree in v-fos-transformed
cells.
The identification of 28 conditionally downregulated
probe sets specific to v-Fos transformation raises the pos-
sibility that loss of expression of a subset of these genes
may be due to chromatin modifying mechanisms leading
to gene silencing. Included in our analysis are several
genes previously implicated as targets for gene silencing
via epigenetic repression. For example, the extracellular
matrix molecule, SPARC, is downregulated in c-jun-trans-
formed primary rat embryo fibroblasts [26]. Also, in v-jun-
transformed chick embryo fibroblasts, reduction in
SPARC mRNA levels has been shown to be due in part to
the formation of a DNA-Sp1/3-v-Jun chromatin-associ-
ated complex [27]. Tissue inhibitor of metalloprotease 2
(TIMP-2), an endogenous inhibitor of MMP-2, has been
shown to inhibit invasion and metastasis [28] and overex-
pression of TIMP-2 inhibited growth and reduced invasive
potential in tumor cells [29]. TIMP-2 is subject to aberrant
promoter hypermethylation in human cervical cancer
cells and increased methylation favors development of
primary cervical cancers [30]. Interestingly, treatment of
human neuroblastoma cells with the DNA methyltrans-
ferase inhibitor 5-azacytidine (5-AzaC) restored TIMP-2
expression and resulted in a reduction of in vitro invasive-
ness [31]. The precise role of v-fos  in mediating gene
silencing in the conditional system is not clear; however,
our system represents a tool for identifying candidate
genes that are subject to epigenetic modification during
the process of oncogenesis, as well as a conditional cellu-
lar system that can be employed to investigate the tempo-
ral mechanisms underlying these regulatory events.
Conclusion
Technological advances in the ability to analyze gene
expression profiles on an increasingly global scale have
contributed significantly to a more comprehensive view of
the complex transcriptional networks that go awry in
tumor cells [32,33]. Studies of in vitro cellular model sys-
tems of oncogenic transformation have provided a wealth
of information relevant to both normal signal transduc-
tion pathways and tumorigenic mechanisms. However,
the large number of genes differentially expressed in these
model systems often complicates the identification of the
most promising candidate genes for further study. Our
web-accessible database of transcriptional changes
detected in the conditional v-fos system provides a power-
ful tool to identify cohorts of gene candidates associated
with specific cellular events during the process of transfor-
mation and reversion.Molecular Cancer 2005, 4:19 http://www.molecular-cancer.com/content/4/1/19
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Methods
Cell culture and v-fos transformation and reversion time 
course
All cells were maintained in DMEM supplemented with
10% fetal calf serum, L-glutamine and penicillin/strepto-
mycin at 37°C in the presence of 5% CO2. Establishment
of the stably transformed cell lines, FBJ/R and CMVc-fos,
was described previously [9]. Establishment of the LacIv-
fos conditional cell line and the conditions required for
the transformation/reversion time course were described
previously [11]. Briefly, for the v-fos transformation and
reversion time course experiment, total RNA was extracted
from LacIv-fos cells cultured in the presence of 5 mM IPTG
at time zero; 24, 48 and 72 hours after removal of IPTG
(transforming); and 24, 48 and 72 hours after the re-addi-
tion of 5 mM IPTG (reverting). Total RNA was extracted
from cells by using Tripure reagent according to the man-
ufacturer's instructions (Roche). The integrity of all RNA
samples was verified by using an Agilent 2100
Bioanalyzer.
Western blot and immunofluorescence analyses
Expression of Fos protein during transformation and
reversion was evaluated by Western blotting analysis
using an antibody directed against Fos [7]. Whole-cell
lysates were prepared in lysis buffer (20 mM Tris pH 7.5,
100 mM NaCl, 0.5% NP-40, protease inhibitor cocktail
[Roche]) and separated on a 12% SDS-polyacrylamide
gel. For immunofluorescence microscopy, cells were fixed
in 4% (w/v) formaldehyde. Fixed cells were incubated
with primary mouse monoclonal anti-vinculin antibody
(Sigma; dilution of 1:200) and phalloidin-congjugated to
Alexa-568 (Molecular Probes). An anti-mouse secondary
antibody (dilution of 1:1000) conjugated to Alexa-488
(Molecular Probes) was used to detect vinculin.
Microarray analyses
RNA samples were processed for hybridization without
amplification and hybridized to Affymetrix Rat Genome
U34A GeneChips that include probe sets representing
approximately 7,000 annotated genes and 1,000 EST
clones [34]. Labelling and hybridization were preformed
as described [35]. GeneChips were scanned using a laser
confocal scanner (Agilent Technologies) and images were
analyzed using Affymetrix Microarray Suite v.5.0. Datasets
were standardized by global scaling of the average fluores-
cent intensities of all probe sets to a constant target value
of 500 for all arrays. Quality control parameters for each
hybridization were within MIAME compliant specifica-
tions [36]. A variance filter was applied to the dataset to
remove data from probe sets representing genes that were
not expressed throughout the time course and to stand-
ardize expression values for genes whose expression was
scored absent at particular time points [37]. Data that
were derived from probe sets that reported absent change
calls at all seven time points were removed from the anal-
ysis. To standardize expression values of genes whose
expression was scored as absent at fewer than seven time
points, we converted the signal values that corresponded
to absent change calls to a value of 1. Genes scored as dif-
ferentially expressed in CMVc-fos cells and FBJ/R cells rel-
ative to 208F cells had a signal log ratio ≥  1 (increased) or
≤  -1 (decreased), and a change p-value < 0.001 (increased)
or > 0.99 (decreased). For visualization of specific profiles
of gene expression during the LacIv-fos conditional trans-
formation and reversion time course, signal values
obtained at each LacIv-fos time point were plotted by
using Microsoft Excel.
SOM analysis
Microarray data that were obtained from the LacIv-fos
time course experiments and passed the variance filter
were grouped into relative expression pattern bins by the
self-organizing map (SOM) program in the GeneMaths
software package (version 1.5; Applied Maths, Austin,
TX). The SOM analysis was performed by using a 6 × 3
node format to allow optimal representation of gene
expression patterns in a reasonably small number of inde-
pendent bins.
The SOM searchable database
The SOM searchable database has been implemented on
an Open Source MySQL 4.0.14 relational database man-
agement system. The database has a web interface at http:/
/www.stjuderesearch.org/v-fosSOM/. The web applica-
tion to query and manage the database is driven with a
server-side scripting technology JSP. The entries of this
database are generated from the tab-delimited output files
of the SOM analysis. Data obtained from the SOM analy-
sis can be queried by three approaches. Users can click on
a graphical pattern key to view a list of all genes whose
expression profiles match the particular self-organization
pattern. Each entry in the list contains two parameters
associated with the respective gene probe, i.e., the Affyme-
trix probe set ID number and a description of the gene.
The detailed Affymetrix analysis data for a probe set can be
obtained by clicking the link of the respective probe set ID
number. The corresponding Affymetrix analysis page pro-
vides information about the number of oligonucleotide
pairs, the signal magnitude, the detection status, and the
detection p value at seven different time points derived
from 2 independent experiments. Another search method
is to query via the GenBank accession number. The query
by accession number is based on the fact that each
Affymetrix probe set ID number in our current experi-
ments corresponds to a gene accession number. If an
accession number in a query matches with any part within
a probe set ID number, the entry containing the probe set
ID number, its SOM pattern, and gene description is dis-
played. Hyperlinks are provided for both probe set IDMolecular Cancer 2005, 4:19 http://www.molecular-cancer.com/content/4/1/19
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numbers and SOM pattern. By following the link for a
probe set ID number, the user can view the detailed
Affymetrix analysis data for a selected gene probe; by fol-
lowing the link for an SOM pattern, the user can view the
detailed Affymetrix analysis data for all the gene probes
within the selected pattern. Also, a keyword-based text
search is included in the database. A search for keywords
in the paragraph of the gene description field is conducted
in a case-insensitive manner. The search-by-keyword
method is facilitated by the use of Boolean operations.
The search can narrow or broaden quickly the results of
the search by combining two or more keyword(s) with
only one type of Boolean (and / or) operation.
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